Glenmark Pharmaceuticals Europe Ltd: UK Public Sector Contracts Won & Awards
Companies House: Private Limited Company·Watford·Nationwide (UK)·Main market: Pharmaceutical products
Official UK PPONPRVD-4666-TRCN
i
How many tenders this supplier has won.
Tenders with at least one award to it. Award records are shown too, because one framework can carry many call-offs.
i
How many different public bodies have awarded to this supplier.
Buyers named on its awards, with duplicate names merged.
i
Awards to this supplier in the last 12 months.
Award records dated in the last 12 months, against the two years before.
i
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
A likely retender, not a certain one.
i
Where this supplier has delivered.
Delivery regions published on its awarded tenders. A tender with several regions counts in each.
Where the work was, not where the company is based.
Where they wini
What kind of work is bought here.
Notices by procurement category (CPV). A notice with several categories counts in each.
i
What kind of work is bought here.
Notices by procurement category (CPV). A notice with several categories counts in each.
81 lot-level observations (81 awarded lots, 100%, plus 0 envelope awards without lot links; pending awards included) · top CPV classes
3360 Pharmaceutical products77 observations · 97% · lots3369 Various medicinal products2 observations · 3% · lotsWhere they deliveri
Where this supplier has delivered.
Delivery regions published on its awarded tenders. A tender with several regions counts in each.
Where the work was, not where the company is based.
i
Where this supplier has delivered.
Delivery regions published on its awarded tenders. A tender with several regions counts in each.
Where the work was, not where the company is based.
ITL1 delivery regions on the notice · 52 of 52 awarded procedures publish one · a procedure with several regions counts in each
Bidding recordi
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
i
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
Procurement Act 2023 award notices name every bidder · 8 notices name this supplier, covering 12 lots since 4 Sept 2025 · observed bids, not an estimate
i
Competitions this supplier is known to have bid in.
Lots on Procurement Act 2023 award notices naming it as a bidder, split into won and lost. The lot is the contest: three lots of a ten-lot notice is three wins and seven losses.
i
Frameworks and DPS this supplier got onto.
Lots appointed out of lots applied for. Kept apart from contract wins because almost every compliant bidder gets a place.
i
How many public bodies this supplier has bid to.
Buyers on notices that name it as a bidder, win or lose.
| Notice | Authority | Outcome | Bidders | Published |
|---|---|---|---|---|
| NHS National Generic Pharmaceuticals - Wave 16a | NHS England | appointed to 1 of 2 lots | 125 | 1 Sept 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | NHS England | appointed to 1 of 2 lots | 41 | 6 Jul 2026 |
| NHS National Branded Interim - 1 June 2026 | NHS England | appointed | 53 | 22 May 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | NHS England | not appointed | 14 | 24 Apr 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | NHS England | appointedall 2 lots bid for | 118 | 26 Feb 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | NHS England | appointed | 8 | 30 Jan 2026 |
| NHS National Framework for Generics Housekeeping | NHS England | not appointed | 53 | 22 Dec 2025 |
| NHS National Framework for Transition products (Axitinib and Eltrombopag) | NHS England | not appointed | 15 | 4 Sept 2025 |
Source: bids.details[].tenderers on Procurement Act 2023 notices (from 2025). PCR 2015 notices name no bidders, so earlier contests are invisible here. Latest ten notices shown.
Who they sell toi
Which buyers publish the most notices here.
Buyers ranked by the number of notices, duplicate names merged.
i
Which buyers publish the most notices here.
Buyers ranked by the number of notices, duplicate names merged.
Authorities named on this supplier’s published awards · ranked by distinct procedures · award records explode on framework and DPS panels
i
What kinds of public bodies buy here.
Notices by the buyer’s type as published, otherwise by its name.
- NHS & health 86% (70 awards)
- Central government 10% (8 awards)
- Type not classified 4% (3 awards)
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 22 | 42.3% | 32 | 27 Aug 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | 9 | 17.3% | 17 | 25 May 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 9 | 17.3% | 12 | 23 Sept 2024 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | 7 | 13.5% | 12 | 6 Jan 2026 |
| The NHS Commissioning Board (operating under the name of NHS England) | 3 | 5.8% | 5 | 14 Jan 2022 |
| Regional Business Services Organisation, Procurement and Logistics Service | 1 | 1.9% | 2 | 3 Jul 2026 |
| The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) | 1 | 1.9% | 1 | 7 May 2026 |
Share = of the 52 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
A likely retender, not a certain one.
i
Contracts that finish in the next 18 months.
Published contracts with an end date in that window. No end date, not counted.
A likely retender, not a certain one.
Published end dates only · 12 of 81 awards carry one · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Cancer Medicines (Group 1) | 31 Jan 2027 | £1,925,364 |
| NP49425 Generic and Biosimilar Transition Medicines | 28 Feb 2027 | £64,103,740 |
| Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | 31 Jul 2027 | £3,594,493 |
| Lot 3 - CM/PHG/23/5699/03 Hospital only (housekeeping) products | 30 Sept 2027 | £37,160,000 |
| Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin | 30 Sept 2027 | £25,881,000 |
Recent awards
Latest 30 of 81 award records naming this supplier
Data coverage & method
- Source: Find a Tender OCDS award and contract releases. An award record is one award × this supplier; a procedure can carry many (panels, call-offs).
- Market observations are awarded lots, or one envelope award when the notice publishes no lot links. Region = delivery ITL1 on the notice, not the supplier’s registered address.
- Authority type: official OCDS UK contracting-authority type when the notice publishes one; otherwise a Tenderline name/id class; otherwise “not classified”. Purchasing hubs with no published type stay unclassified.
- No award value is attributable to this supplier alone (values missing, multi-supplier, or framework / DPS ceilings).
- Contract end dates: published on 12 of 81 awards; 5 end within 18 months.
- Each figure’s own method and sample is behind its ; the long form is on Methodology.
- Never shown: contact details, reliability or payment scores, affiliations, predicted wins.
Identifiers consolidated into this page (11 historical Find a Tender publication identifiers)
Official notices referenced this supplier under these publication identifiers. Alias URLs are not separate pages.
Canonical page id: GB-PPON:PRVD-4666-TRCN